1,576 results on '"Haefeli, Walter E"'
Search Results
2. Effect of Clarithromycin, a Strong CYP3A and P-glycoprotein Inhibitor, on the Pharmacokinetics of Edoxaban in Healthy Volunteers and the Evaluation of the Drug Interaction with Other Oral Factor Xa Inhibitors by a Microdose Cocktail Approach
3. Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers
4. The differences in drug disposition gene induction by rifampicin and rifabutin are unlikely due to different effects on important pregnane X receptor (NR1I2) splice variants
5. Acute antiarrhythmic effects of SGLT2 inhibitors–dapagliflozin lowers the excitability of atrial cardiomyocytes
6. Optimierung des Medikamentenmanagements
7. Aufgaben des Medikamentenmanagements
8. Evaluation of Hydroxychloroquine as a Perpetrator on Cytochrome P450 (CYP) 3A and CYP2D6 Activity with Microdosed Probe Drugs in Healthy Volunteers
9. Untapped options to reduce waste from blister packaging for tablets and capsules
10. Rifabutin but not rifampicin can partly out-balance P-glycoprotein induction by concurrent P-glycoprotein inhibition through high affinity binding to the inhibitory site
11. Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin
12. Zum Einsatz von Informationstechnologie zur Verbesserung der Arzneimitteltherapiesicherheit (Memorandum AMTS-IT)
13. Dokumentationsqualität der Medikation in Entlassbriefen – eine Bestandsaufnahme nach Einführung des Rahmenvertrags Entlassmanagement
14. Exploring the heterogeneity in community pharmacist-led medication review studies – A systematic review
15. CYP3A and CYP2C19 Activity Determined by Microdosed Probe Drugs Accurately Predict Voriconazole Clearance in Healthy Adults
16. Comprehensive in vitro analysis evaluating the variable drug–drug interaction risk of rifampicin compared to rifabutin
17. Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine
18. RNA is a pro-apoptotic target of cisplatin in cancer cell lines and C. elegans
19. Burden of intracerebral haemorrhage in Europe: forecasting incidence and mortality between 2019 and 2050
20. Feasibility and Safety of Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia (SANE-01): A Randomized, Double-blind, Placebo-controlled Phase Ib Clinical Trial
21. Frailty as a Marker for the Plasma Concentrations of Direct Oral Anticoagulants in Older Patients: Results of an Exploratory Study
22. Oral bioavailability of microdoses and therapeutic doses of midazolam as a 2-dimensionally printed orodispersible film in healthy volunteers
23. Attitudes of non-participating general practitioners and community pharmacists towards interprofessional medication management in primary care: an interview study
24. Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion
25. How to avoid misinterpretation of dual reporter gene assay data affected by cell damage
26. Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial
27. Event Analysis for Automated Estimation of Absent and Persistent Medication Alerts: Novel Methodology
28. Prevalence and patient-rated relevance of complexity factors in medication regimens of community-dwelling patients with polypharmacy
29. Drug Treatment of Hypercholesterolemia in Older Adults: Focus on Newer Agents
30. Task sharing in an interprofessional medication management program – a survey of general practitioners and community pharmacists
31. HIOPP-6 – a pilot study on the evaluation of an electronic tool to assess and reduce the complexity of drug treatment considering patients’ views
32. Dose‐dependent induction of CYP3A activity by St. John's wort alone and in combination with rifampin.
33. The influence of intervention complexity on barriers and facilitators in the implementation of professional pharmacy services – A systematic review
34. Customization of information on adverse drug reactions according to patients’ needs – A qualitative study
35. Application of triple quadrupole tandem mass spectrometry to the bioanalysis of collision-induced dissociation-resistant cyclic peptides – Ultra-sensitive quantification of the somatostatin-analog pasireotide utilizing UHPLC-MS/MS
36. A prognostic model predicted deterioration in health-related quality of life in older patients with multimorbidity and polypharmacy
37. Coping resources of heart failure patients – a comparison with cancer patients and individuals having no chronic condition results from the esther study
38. Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations: A case report.
39. Ultra-sensitive bioanalysis of the therapeutic peptide exenatide for accurate pharmacokinetic analyses at effective plasma concentrations utilizing UPLC-MS/MS
40. Process of translation and cross-cultural adaptation of two Australian instruments to evaluate the physician-pharmacist collaboration in Germany
41. Information on adverse drug reactions—Proof of principle for a structured database that allows customization of drug information
42. Effect of Tacrolimus Formulation (Prolonged‐Release vs Immediate‐Release) on Its Susceptibility to Drug‐Drug Interactions with St. John's Wort
43. Evaluation of Hydroxychloroquine as a Perpetrator on Cytochrome P450 (CYP) 3A and CYP2D6 Activity with Microdosed Probe Drugs in Healthy Volunteers
44. Bioanalysis of the Ex Vivo Labile PACE4 Inhibitory Peptide Ac-[d-Leu]LLLRVK-Amba in Whole Blood Using Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Quantification
45. Feasibility and safety of sildenafil to repair brain injury secondary to birth asphyxia (SANE-01): A randomized, double-blind, placebo-controlled phase Ib clinical trial
46. Effectiveness of a multicomponent lifestyle intervention against cognitive decline and dementia in an at‐risk‐population in Germany – Preliminary results of the cluster‐randomized AgeWell.de‐trial
47. Untapped options to reduce waste from blister packaging for tablets and capsules
48. Protocol of the IntenSify‐Trial: An open‐label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab‐paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy
49. Patient Experiences With Handling of Analgesic Transdermal Patches and Challenges in Correct Drug Administration : A Pilot Study on Patient Education
50. Association of mental demands in the workplace with cognitive function in older adults at increased risk for dementia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.